scholarly journals Nutritional Factors in Central Metabolic Regulation

Author(s):  
Alfrēds Jānis Sīpols

Abstract The control of metabolism by direct negative feedback of macronutrients detected centrally has been until recently an attractive, though unconfirmed, hypothesis in the homeostatic model of energy regulation. Research advances in the last decade have greatly expanded our knowledge of how circulating carbohydrates, lipids, and proteins, reflecting amounts of recently ingested macronutrients, are detected in hypothalamic areas to not only regulate food intake, but also direct metabolic processes responsible for energy balance and anabolic pathways. For example, plasma glucose sensed centrally is a major regulator of hepatic glucose production, a process most likely mediated by ATP-sensitive potassium channels. More surprising, circulating lipids detected by hypothalamic structures also act as potent negative feedback regulators of glucose mobilization in the liver, independent of their peripheral detection in the intestines. Finally, central detection of circulating postprandial leucine levels has been shown to decrease abdominal fat mass mobilization and thermogenesis. These findings are consistent with the hypothesis that recognition of macronutrients directly by hypothalamic receptors plays a pivotal role in central regulation of metabolic processes. Moreover, the elucidated mechanisms suggest promising potential sites for pharmacological intervention in the treatment of obesity, already at epidemic proportions, although our modern environment is clearly the major cause.

Endocrinology ◽  
2010 ◽  
Vol 151 (12) ◽  
pp. 5741-5750 ◽  
Author(s):  
P. M. Yamada ◽  
H. H. Mehta ◽  
D. Hwang ◽  
K. P. Roos ◽  
A. L. Hevener ◽  
...  

IGF-binding protein (IGFBP)-3 is a metabolic regulator that has been shown to inhibit insulin-stimulated glucose uptake in murine models. This finding contrasts with epidemiological evidence of decreased serum IGFBP-3 in patients with type 2 diabetes. The purpose of this study was to clarify the role of IGFBP-3 in metabolism. Four-week-old male IGFBP-3−/− and control mice were subjected to a high-fat diet (HFD) for 12 wk. IGFBP-3−/− mice were heavier before the initiation of HFD and at the end of the study period. Resting metabolic rate was significantly decreased in knockout mice; however, respiratory exchange ratio was not significantly different. Fasting blood glucose and insulin levels were significantly elevated in IGFBP-3−/− mice. However, IGFBP-3−/− mice had relatively normal glucose tolerance because the relative glucose excursion over time was not different between the groups. During hyperinsulinemic clamps, IGFBP-3−/− mice had increased basal hepatic glucose production, but after insulin stimulation, no differences in hepatic glucose production were observed. A second cohort of older IGFBP-3−/− mice on HFD displayed unexpected evidence of hepatic steatosis. In summary, glucose tolerance and clamp testing indicate that IGFBP-3−/− mice preserve insulin sensitivity despite evidence of increased basal glucose turnover and hepatic steatosis. We provide evidence that genetic deletion of IGFBP-3 modulates hepatic carbohydrate and lipid metabolism.


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Frank A. Duca ◽  
T. M. Zaved Waise ◽  
Willem T. Peppler ◽  
Tony K. T. Lam

AbstractThe gastrointestinal tract maintains energy and glucose homeostasis, in part through nutrient-sensing and subsequent signaling to the brain and other tissues. In this review, we highlight the role of small intestinal nutrient-sensing in metabolic homeostasis, and link high-fat feeding, obesity, and diabetes with perturbations in these gut-brain signaling pathways. We identify how lipids, carbohydrates, and proteins, initiate gut peptide release from the enteroendocrine cells through small intestinal sensing pathways, and how these peptides regulate food intake, glucose tolerance, and hepatic glucose production. Lastly, we highlight how the gut microbiota impact small intestinal nutrient-sensing in normal physiology, and in disease, pharmacological and surgical settings. Emerging evidence indicates that the molecular mechanisms of small intestinal nutrient sensing in metabolic homeostasis have physiological and pathological impact as well as therapeutic potential in obesity and diabetes.


2013 ◽  
Vol 51 (01) ◽  
Author(s):  
S Gul ◽  
KH Holzmann ◽  
F Leithäuser ◽  
H Maier ◽  
B Böhm ◽  
...  

1989 ◽  
Vol 120 (3_Suppl) ◽  
pp. S20
Author(s):  
M.J. MÜLLER ◽  
K.J. ACHESON ◽  
A. G. BURGER ◽  
E. JEQUIER ◽  
A. VON ZUR MÜHLEN

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2441-PUB ◽  
Author(s):  
QUAN PAN ◽  
YUNMEI CHEN ◽  
HUI YAN ◽  
WANBAO YANG ◽  
ZHENG SHEN ◽  
...  

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 64-LB
Author(s):  
JEONGRIM KO ◽  
TAE NYUN KIM ◽  
DAE YUN SEO ◽  
JIN HAN

Diabetes ◽  
1986 ◽  
Vol 35 (2) ◽  
pp. 186-191 ◽  
Author(s):  
I. Hansen ◽  
R. Firth ◽  
M. Haymond ◽  
P. Cryer ◽  
R. Rizza

Sign in / Sign up

Export Citation Format

Share Document